RPO LLC has filed its 13F-HR report for the quarter ending September 30, 2026, revealing a total portfolio value of approximately $93 million. This filing is significant as it provides insights into the company's investment strategies and highlights its growing interest in exchange-traded funds (ETFs), particularly those related to cryptocurrencies.
The report indicates that RPO LLC is actively investing in various ETFs, including those focused on digital assets. This trend suggests a strategic pivot towards sectors that are gaining traction in the investment community. The filing details 35 different holdings, showcasing a diverse range of investments.
Background
RPO LLC is a private investment firm based in Stamford, Connecticut. The company is registered with the SEC under the Central Index Key (CIK) number 0001885066. According to its recent filings, RPO LLC has been consistently reporting its holdings, with the latest submission being its 13F-HR form filed on November 12, 2026. The firm does not have publicly traded tickers or exchanges listed, indicating its private nature.
What the Filing Says
The filing states, "The total value of the holdings is $93,223,240 as of September 30, 2026." This figure reflects the firm's investment strategy and portfolio management approach, focusing on maximizing returns through a diversified asset base.
Impact
This update may affect various stakeholders, including investors and competitors in the ETF market. As RPO LLC continues to expand its portfolio, other firms may need to reassess their strategies to remain competitive. The growing interest in cryptocurrency-related ETFs could signal a shift in market dynamics, prompting other investment firms to explore similar avenues.
What's Next
The filing does not say what happens next.
Read Next
Silvia, Inc. updates stock compensation for CEO Pompliano
FG Communities Holdings declares quarterly cash dividend
Solmate Infrastructure Expands into AI Compute Services
Bitmine Immersion Technologies announces operational update
ASOF Investment Management Acquires 13,587 Shares of Claritev
Belite Bio CMO Scholl Hendrik Peter Sells 2,000 Shares








